BACKGROUND: Impaired cerebral autoregulation may predispose patients to cerebral hypoperfusion during cardiopulmonary bypass (CPB). The purpose of this study was to identify risk factors for impaired autoregulation during coronary artery bypass graft, valve surgery with CPB, or both and to evaluate whether near-infrared spectroscopy (NIRS) autoregulation monitoring could be used to identify this condition. METHODS: Two hundred and thirty-four patients were monitored with transcranial Doppler and NIRS. A continuous, moving Pearson's correlation coefficient was calculated between mean arterial pressure (MAP) and cerebral blood flow (CBF) velocity, and between MAP and NIRS data, to generate the mean velocity index (Mx) and cerebral oximetry index (COx), respectively. Functional autoregulation is indicated by an Mx and COx that approach zero (no correlation between CBF and MAP); impaired autoregulation is indicated by an Mx and COx approaching 1. Impaired autoregulation was defined as an Mx ≥0.40 at all MAPs during CPB. RESULTS: Twenty per cent of patients demonstrated impaired autoregulation during CPB. Based on multivariate logistic regression analysis, time-averaged COx during CPB, male gender, Pa(CO(2)), CBF velocity, and preoperative aspirin use were independently associated with impaired CBF autoregulation. Perioperative stroke occurred in six of 47 (12.8%) patients with impaired autoregulation compared with five of 187 (2.7%) patients with preserved autoregulation (P=0.011). CONCLUSIONS: Impaired CBF autoregulation occurs in 20% of patients during CPB. Patients with impaired autoregulation are more likely than those with functional autoregulation to have perioperative stroke. Non-invasive monitoring autoregulation may provide an accurate means to predict impaired autoregulation. Clinical trials registration. www.clinicaltrials.gov (NCT00769691).
BACKGROUND: Impaired cerebral autoregulation may predispose patients to cerebral hypoperfusion during cardiopulmonary bypass (CPB). The purpose of this study was to identify risk factors for impaired autoregulation during coronary artery bypass graft, valve surgery with CPB, or both and to evaluate whether near-infrared spectroscopy (NIRS) autoregulation monitoring could be used to identify this condition. METHODS: Two hundred and thirty-four patients were monitored with transcranial Doppler and NIRS. A continuous, moving Pearson's correlation coefficient was calculated between mean arterial pressure (MAP) and cerebral blood flow (CBF) velocity, and between MAP and NIRS data, to generate the mean velocity index (Mx) and cerebral oximetry index (COx), respectively. Functional autoregulation is indicated by an Mx and COx that approach zero (no correlation between CBF and MAP); impaired autoregulation is indicated by an Mx and COx approaching 1. Impaired autoregulation was defined as an Mx ≥0.40 at all MAPs during CPB. RESULTS: Twenty per cent of patients demonstrated impaired autoregulation during CPB. Based on multivariate logistic regression analysis, time-averaged COx during CPB, male gender, Pa(CO(2)), CBF velocity, and preoperative aspirin use were independently associated with impaired CBF autoregulation. Perioperative stroke occurred in six of 47 (12.8%) patients with impaired autoregulation compared with five of 187 (2.7%) patients with preserved autoregulation (P=0.011). CONCLUSIONS: Impaired CBF autoregulation occurs in 20% of patients during CPB. Patients with impaired autoregulation are more likely than those with functional autoregulation to have perioperative stroke. Non-invasive monitoring autoregulation may provide an accurate means to predict impaired autoregulation. Clinical trials registration. www.clinicaltrials.gov (NCT00769691).
Authors: Marcel J H Aries; Jan W Elting; Jacques De Keyser; Berry P H Kremer; Patrick C A J Vroomen Journal: Stroke Date: 2010-10-07 Impact factor: 7.914
Authors: C S Burkhart; A Rossi; S Dell-Kuster; M Gamberini; A Möckli; M Siegemund; M Czosnyka; S P Strebel; L A Steiner Journal: Br J Anaesth Date: 2011-08-10 Impact factor: 9.166
Authors: Brian M Deegan; Farzaneh A Sorond; Andrew Galica; Lewis A Lipsitz; Gearoid O'Laighin; Jorge M Serrador Journal: Stroke Date: 2011-05-12 Impact factor: 7.914
Authors: Kenneth Brady; Brijen Joshi; Christian Zweifel; Peter Smielewski; Marek Czosnyka; R Blaine Easley; Charles W Hogue Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: Marek Czosnyka; Ken Brady; Matthias Reinhard; Piotr Smielewski; Luzius A Steiner Journal: Neurocrit Care Date: 2009-01-06 Impact factor: 3.210
Authors: Luzius A Steiner; Marek Czosnyka; Stefan K Piechnik; Piotr Smielewski; Doris Chatfield; David K Menon; John D Pickard Journal: Crit Care Med Date: 2002-04 Impact factor: 7.598
Authors: Andrew Laflam; Brijen Joshi; Kenneth Brady; Gayane Yenokyan; Charles Brown; Allen Everett; Ola Selnes; Edward McFarland; Charles W Hogue Journal: Anesth Analg Date: 2015-01 Impact factor: 5.108
Authors: D Hori; C Brown; M Ono; T Rappold; F Sieber; A Gottschalk; K J Neufeld; R Gottesman; H Adachi; C W Hogue Journal: Br J Anaesth Date: 2014-09-25 Impact factor: 9.166
Authors: Paul Pham; Jessica Bindra; Anders Aneman; Alwin Chuan; John M Worthington; Matthias Jaeger Journal: Neurocrit Care Date: 2019-02 Impact factor: 3.210
Authors: Charles H Brown; Karin J Neufeld; Jing Tian; Julia Probert; Andrew LaFlam; Laura Max; Daijiro Hori; Yohei Nomura; Kaushik Mandal; Ken Brady; Charles W Hogue; Ashish Shah; Kenton Zehr; Duke Cameron; John Conte; O Joseph Bienvenu; Rebecca Gottesman; Atsushi Yamaguchi; Michael Kraut Journal: JAMA Surg Date: 2019-09-01 Impact factor: 14.766
Authors: Masahiro Ono; Charles Brown; Jennifer K Lee; Rebecca F Gottesman; Michael Kraut; James Black; Ashish Shah; Duke E Cameron; William Baumgartner; Charles W Hogue Journal: Ann Thorac Surg Date: 2013-12 Impact factor: 4.330